Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Join PfizerLink — a clinical research registry

      Get notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit.

      Sign up

      Sickle Cell Disease clinical trial

      The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

      Get started

      60 trials found cancer

      All(60)
      Recruiting(54)
      Not yet recruiting(6)
      2 trials recruiting
      Pfizer Breast Cancer Clinical Trials

      Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.

      Recruiting
      NCT06012435
      A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

      Carcinoma, Non-Small-Cell Lung

      Male or Female
      18+ years
      30study location(s)
      Recruiting
      NCT05090566
      MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

      Multiple Myeloma

      Male or Female
      18+ years
      84study location(s)
      Recruiting
      NCT05355701
      A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

      Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma

      Male or Female
      16+ years
      84study location(s)
      Recruiting
      NCT05654623
      A Study to Learn About a New Medicine Called ARV-471 (PF-07850327) in People Who Have Advanced Metastatic Breast Cancer.

      Advanced Breast Cancer

      Male or Female
      18+ years
      664study location(s)
      Recruiting
      NCT05217446
      A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

      Metastatic Colorectal Cancer

      Male or Female
      16+ years
      204study location(s)
      Recruiting
      NCT04607421
      A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

      Neoplasms

      Male or Female
      16+ years
      750study location(s)
      Recruiting
      NCT04553133
      PF-07104091 as a Single Agent and in Combination Therapy

      Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer

      Male or Female
      18+ years
      80study location(s)
      Recruiting
      NCT05253651
      A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

      Colorectal Neoplasms

      Male or Female
      18+ years
      140study location(s)
      Recruiting
      NCT03975647
      A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

      HER2-positive Breast Cancer

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT05132582
      A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

      HER2 Positive Breast Cancer

      Male or Female
      18+ years
      181study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(60)
      Recruiting(54)
      Not yet recruiting(6)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.